Impact of Disease on the Concept of End-of-life Decisions of the Elderly in the Community
NCT ID: NCT01519622
Last Updated: 2012-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
88 participants
OBSERVATIONAL
2012-02-29
2013-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Participatory Patient Care Planning in Primary Care
NCT02992431
Reducing Cardiovascular Risk in Primary Care: a Randomized Clinical Trial
NCT05395806
Patients' Perception of Climate Change and Healthcare
NCT05816447
mHealth Interventions to Improve Access and Coverage of Uninsured People With High Cardiovascular Risk in Argentina.
NCT02913339
Evaluation of a Socio-ecological Cardiovascular Disease Prevention Intervention for Ultra-Orthodox Jewish Hasidic Women
NCT03201523
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Population and sample: The target population will be elderly and healthy community elderly population was accessible due to a special branch of the club together in the center of the country. Sample to be a sample of convenience. The study will include 88 seniors aged 65 and over to get the power of 0.80 and alfa 0.05, Tools: The study used three tools.
* The first tool is a questionnaire on demographic and clinical details
* The second tool questionnaire the Long term support program (LTSP)
* The third tool is a questionnaire perception of the disease Revised Illness Perceptions Questionnaire (IPQR)
The research process:
Investigator will present the proposal to the Commissioner Fund hospitals and request approval for the study. After receiving approval from the director Department of Health fund the hospital will make data collection phase HMO, days and hours of reception. Interrogator he is to partition the questionnaires and will be present when filling out the questionnaires to help, if and created a situation of lack of understanding of the questionnaires. Scholar, came to the population for the Disabled arriving at the clinic visit, and introduce himself and the subject of research. investigator will indicate questionnaire is anonymous.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sick elderly in community
Questionnaire
Questionnaire to be distributed among sick elderly in the community
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Questionnaire
Questionnaire to be distributed among sick elderly in the community
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Literate in Hebrew
* Treated in community HMO
Exclusion Criteria
* History of mental illness
* Cognitive problems
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir Medical Center
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
K202/2011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.